Postdischarge Contacts Do Not Reduce 30-Day ED Visits, Readmissions

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 13, 2025 -- Postdischarge contacts (PDCs) with patients after hospitalization are not associated with reductions in 30-day emergency department use or 30-day readmissions, according to a systematic review and meta-analysis published online Jan. 14 in the Annals of Internal Medicine.

Joel C. Boggan, M.D., M.P.H., from the Durham Veterans Affairs Health Care System in North Carolina, and colleagues examined the effects of PDCs within seven days on 30-day emergency department visits, 30-day hospital readmissions, and patient satisfaction in a review of 13 studies (11 randomized trials).

Twelve of the studies delivered PDCs via telephone. Of the 11 randomized trials, three and one were rated as having low and high risk for bias, respectively. The researchers found that of the PDC interventions, most (10 PDCs) consisted of single telephone contacts, often within three days. Eight of the studies focused on patients who were identified by the authors as being at higher risk. No differences were seen in 30-day emergency department use or 30-day readmissions with PDCs.

"Although our review did not find evidence of significant effects of brief PDC approaches, health care systems should consider the cost-effectiveness of these relatively light-touch approaches on such costly outcomes as hospital readmissions," the authors write. "Such considerations of widespread universal brief PDCs should be balanced with the potential to target investments in more intensive postdischarge approaches focused on patients most likely to benefit from these interventions."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-14 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords